🇺🇸 FDA

Intelligence · Clinical Pipeline

Autoimmune & immunology · Phase III

Autoimmune & immunology programs at Phase III — ClinicalTrials.gov pipeline intelligence.

Programs
368

Quick answer

Autoimmune & immunology Phase III programs: NovaPharmaNews indexes 368 matching clinical development programs from ClinicalTrials.gov with sponsor, modality, and NCT cross-links.

Top sponsors

Page 2 of 8

  1. BOTOX 50 UNITÉS ALLERGAN, poudre pour solution injectable, SODIUM CHLORIDE

    Pari Pharma GmbH

    Adults aged at least 18 years with painful base-of-thumb osteoarthritis

    phase 3 small molecule active

    1 trial

  2. Baricitinib

    Eli Lilly and Company

    Systemic Lupus Erythematosus

    phase 3 small molecule terminated

    1 trial

  3. Baricitinib

    Eli Lilly and Company

    Systemic Juvenile Idiopathic Arthritis

    phase 3 small molecule active

    1 trial

  4. Budesonide

    Bausch + Lomb Ireland Limited

    Colitis, Ulcerative

    phase 3 small molecule completed

    1 trial

  5. Bupivacaine Liposome Injection

    United Therapeutics Europe Ltd

    Osteoarthritis

    phase 3 small molecule terminated

    1 trial

  6. CEP-33457

    Teva Pharma GmbH

    Systemic Lupus Erythematosus

    phase 3 small molecule completed

    2 trials

  7. CF101

    Can-Fite BioPharma

    Plaque Psoriasis

    phase 3 small molecule completed

    1 trial

  8. CF101 1 mg

    Can-Fite BioPharma

    Rheumatoid Arthritis

    phase 3 small molecule terminated

    1 trial

  9. CF101 2mg

    Can-Fite BioPharma

    Plaque Psoriasis

    phase 3 small molecule completed

    1 trial

  10. CHS-0214

    Coherus Oncology

    Rheumatoid Arthritis

    phase 3 small molecule completed

    1 trial

  11. CHS-1420

    Coherus Oncology

    Plaque Psoriasis

    phase 3 small molecule completed

    1 trial

  12. CIPROFLOXACIN, Upadacitinib, Upadacitinib, METHOTREXATE, SULFASALAZINE, Upadacitinib, Upadacitinib, DEXAMETHASONE, Upadacitinib

    AbbVie Deutschland GmbH & Co. KG

    Crohn's Disease (CD)

    phase 3 small molecule active

    1 trial

  13. CLS2901C (human [allogeneic] chondrocyte sheets)

    CellSeed Europe Ltd

    Osteoarthritis of the Knee

    phase 3 mab active

    1 trial

  14. CONDROSULF 800 mg tabletta

    The George Institute

    Knee osteoarthritis with moderate to severe pain

    phase 3 small molecule active

    1 trial

  15. CP-690,550

    Pfizer

    Arthritis, Rheumatoid

    phase 3 small molecule completed

    3 trials

  16. CT-P55, Cosentyx 150 mg solution for injection in pre-filled syringe

    Celltrion Healthcare Australia Pty Ltd

    Plaque psoriasis

    phase 3 small molecule active

    1 trial

  17. Cardioblate® Surgical Ablation System

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Rheumatic Valve Disease

    phase 3 other active

    1 trial

  18. Cenerimod

    Viatris Pharmaceuticals Co.,

    Lupus Erythematosus, Systemic

    phase 3 small molecule active

    2 trials

  19. Cenerimod 4 mg

    Viatris Pharmaceuticals Co.,

    Systemic lupus erythematosus

    phase 3 small molecule active

    1 trial

  20. Cenerimod 4 mg, Cenerimod matching placebo

    Viatris Pharmaceuticals Co.,

    Moderate to severe systemic lupus erythematosus

    phase 3 small molecule active

    1 trial

  21. Cenerimod matching placebo, Cenerimod 4 mg

    Viatris Pharmaceuticals Co.,

    Moderate to severe systemic lupus erythematosus

    phase 3 small molecule active

    1 trial

  22. Clinical study to compare the therapeutic effects of two ointments with active substances betamethasone dipropionate and salicylic acid and of one ointment without active substances for patients with chronic stable plaque poriasis

    Alphapharm Pty Ltd

    Chronic stable plaque psoriasis

    phase 3 other active

    1 trial

  23. Cx601

    Takeda

    Crohn's Disease

    phase 3 other completed

    3 trials

  24. Darvadstrocel

    Takeda

    Complex Perianal Fistulas in Adult Participants With Crohn's Disease

    phase 3 mab completed

    1 trial

  25. Delayed and extended release mesalazine

    Takeda

    Colitis, Ulcerative

    phase 3 small molecule completed

    1 trial

  26. Dexamethasone

    Quince Therapeutics

    Crohn's Disease

    phase 3 small molecule terminated

    1 trial

  27. Diclofenac Sodium Topical Gel, 1%

    Amneal Pharma Europe Ltd

    Osteoarthritis

    phase 3 small molecule completed

    1 trial

  28. Donepezil

    Universal Integrated

    Osteoarthritis

    phase 3 small molecule active

    1 trial

  29. Double-blind 200 mg imsidolimab

    Vanda Pharmaceuticals Netherlands B.V.

    Generalized Pustular Psoriasis

    phase 3 small molecule terminated

    1 trial

  30. Duloxetine

    Pacira Ireland Limited

    Knee Osteoarthritis

    phase 3 small molecule completed

    1 trial

  31. Duvakitug

    Teva Pharma GmbH

    Ulcerative Colitis

    phase 3 small molecule active

    2 trials

  32. Duvakitug

    Teva Pharma GmbH

    Crohn's Disease

    phase 3 small molecule active

    2 trials

  33. EFGARTIGIMOD ALFA, JNJ-80202135

    Janssen-Cilag International N.V.

    generalized myasthenia gravis

    phase 3 small molecule active

    1 trial

  34. ENTECAVIR , VAY736, Placebo to VAY736 300 mg/2 mL Solution for injection in pre-filled syringe, Placebo to VAY736 300 mg/2 mL Solution for injection in pre-filled pen, TENOFOVIR ALAFENAMIDE , -, VAY736, TENOFOVIR DISOPROXIL

    Novartis Pharmaceuticals

    Systemic Lupus Erythematosus

    phase 3 small molecule active

    1 trial

  35. Enbrel 50 mg solution for injection in pre-filled syringe, Enbrel 50 mg solution for injection in pre-filled syringe

    Mabxience Research SL

    Rheumatoid Arthritis

    phase 3 small molecule active

    1 trial

  36. Enbrel 50 mg solution for injection in pre-filled syringe, Guselkumab - solution for injection in pre-filled syringe - 100 mg/mL, Guselkumab 1 mL PFS Placebo, Guselkumab, Guselkumab 0.5 mL Varioject Placebo, Enbrel 25 mg powder and solvent for solution for injection

    Janssen-Cilag International N.V.

    Chronic Plaque Psoriasis

    phase 3 small molecule active

    1 trial

  37. Enema transplant of fecal microbiota, Placebo Enema transplant of fecal microbiota

    Pari Pharma GmbH

    Adult patients with ulcerative colitis diagnosed for at least 3 months

    phase 3 small molecule active

    1 trial

  38. Entyvio 108 mg solution for injection in pre-filled syringe, Entyvio 108 mg solution for injection in pre-filled pen

    Takeda

    Ulcerative Colitis or Crohn’s Disease

    phase 3 small molecule active

    1 trial

  39. Entyvio 108 mg solution for injection in pre-filled syringe, Entyvio 300 mg powder for concentrate for solution for infusion

    Takeda

    Active Ulcerative Colitis or Crohn’s Disease

    phase 3 small molecule active

    1 trial

  40. Etanercept

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Rheumatoid Arthritis

    phase 3 small molecule active

    1 trial

  41. Etanercept

    Coherus Oncology

    Rheumatoid Arthritis

    phase 3 small molecule completed

    1 trial

  42. Etanercept

    Coherus Oncology

    Plaque Psoriasis

    phase 3 small molecule completed

    1 trial

  43. Etrasimod Arginine Blue

    Lacuna Pharma Pty Ltd

    Ulcerative Colitis

    phase 3 small molecule active

    1 trial

  44. Etrasimod Arginine Blue Placebo, Etrasimod Arginine Blue, Etrasimod Arginine Blue

    Lacuna Pharma Pty Ltd

    Crohn's Disease

    phase 3 small molecule active

    1 trial

  45. FX006

    Pacira Ireland Limited

    Osteoarthritis of the Knee

    phase 3 small molecule completed

    2 trials

  46. FX006

    Pacira Ireland Limited

    Osteoarthritis, Hip

    phase 3 small molecule terminated

    1 trial

  47. FX006 32 mg

    Pacira Ireland Limited

    Osteoarthritis of the Knee

    phase 3 small molecule completed

    4 trials

  48. FX006 32 mg

    Pacira Ireland Limited

    Osteoarthritis, Knee

    phase 3 small molecule completed

    1 trial

Frequently asked questions

How many autoimmune & immunology Phase III programs exist?

368 programs match both the therapeutic area and stage filters in our published index.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.